Comparative evaluation of the effectiveness of spirinolactone and eplerenone in patients with different left ventricular ejection fraction in chronic heart failure.

Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/6382

Full metadata record

DC Field	Value	Language
dc.contributor.author	Baxronova Yulduzxon, Raximova Matluba, Buranova Sagdiana,	-
dc.date.accessioned	2023-02-20T05:44:05Z	-
dc.date.available	2023-02-20T05:44:05Z	-
dc.date.issued	2023	-
dc.identifier.citation	Toshkent	en_US
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/6382	-
dc.description.abstract	In the article, the scientific literature confirming the effect of spirinolactone and eplerenone, belonging to the group of mineralocorticoid receptor antagonists, on the quality of life, the number of hospitalizations, the outcome of the disease, and the length of life of patients with chronic heart failure was studied, and the effects of these two drugs were comparatively evaluated.	en_US
dc.language.iso	en	en_US
dc.subject	Aldosterone, mineralocorticoid receptor antagonists, veroshpiron, eplerenone	en_US
dc.title	Comparative evaluation of the effectiveness of spirinolactone and eplerenone in patients with different left ventricular ejection fraction in chronic heart failure.	en_US
dc.type	Thesis	en_US
Appears in Collections:	Thesis, Articles

Files in This Item:

File	Description	Size	Format
2. Рахимова Матлуба Эшбаевна, Буранова Сагдияна Насуруллаевна,.pdf	Comparative evaluation of the effectiveness of spirinolactone and eplerenone in patients with different left ventricular ejection fraction in chronic heart failure.	786.47 kB	Adobe PDF	View/Open

DSpace JSPUI